Park Avenue Securities LLC Sells 1,342 Shares of Zoetis Inc. (NYSE:ZTS)

Park Avenue Securities LLC decreased its stake in Zoetis Inc. (NYSE:ZTS) by 5.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 23,151 shares of the company’s stock after selling 1,342 shares during the quarter. Park Avenue Securities LLC’s holdings in Zoetis were worth $4,523,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the stock. Price T Rowe Associates Inc. MD increased its position in shares of Zoetis by 31.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after buying an additional 3,244,074 shares in the last quarter. Sarasin & Partners LLP grew its stake in Zoetis by 546.3% in the second quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company’s stock valued at $390,682,000 after acquiring an additional 1,904,899 shares during the period. Swedbank AB bought a new stake in shares of Zoetis in the first quarter worth about $210,815,000. Marshall Wace LLP raised its position in shares of Zoetis by 7,608.6% during the second quarter. Marshall Wace LLP now owns 835,684 shares of the company’s stock worth $144,874,000 after purchasing an additional 824,843 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in shares of Zoetis by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 40,334,966 shares of the company’s stock valued at $7,960,912,000 after purchasing an additional 536,477 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Zoetis Stock Down 0.5 %

ZTS stock opened at $190.03 on Friday. Zoetis Inc. has a 1-year low of $144.80 and a 1-year high of $201.92. The business’s 50 day simple moving average is $187.30 and its 200 day simple moving average is $175.47. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. The firm has a market capitalization of $86.71 billion, a PE ratio of 36.61, a PEG ratio of 2.95 and a beta of 0.89.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The company had revenue of $2.36 billion during the quarter, compared to analysts’ expectations of $2.31 billion. During the same quarter last year, the company posted $1.41 EPS. Zoetis’s quarterly revenue was up 8.3% compared to the same quarter last year. As a group, research analysts anticipate that Zoetis Inc. will post 5.84 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on ZTS shares. Stifel Nicolaus raised their price objective on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, September 18th. Argus raised Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Piper Sandler boosted their price target on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. Finally, BTIG Research increased their price objective on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $220.38.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.